The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial

BACKGROUND: By 2050, the prevalence of Alzheimer’s disease (AD) in the United States is predicted to reach 13.8 million. Despite worldwide research efforts, a cure for AD has not been identified. Thus, it is critical to identify preventive strategies that can reduce the risk of or delay the onset of...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kyoung Shin, Ganesh, Alexis B., Berry, Nathaniel T., Mobley, Yashonda P., Karper, William B., Labban, Jeffrey D., Wahlheim, Christopher N., Williams, Tomika M., Wideman, Laurie, Etnier, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274941/
https://www.ncbi.nlm.nih.gov/pubmed/32503473
http://dx.doi.org/10.1186/s12883-020-01732-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274941/
https://www.ncbi.nlm.nih.gov/pubmed/32503473
http://dx.doi.org/10.1186/s12883-020-01732-1

Ejemplares similares